Dermatology · Williamsville, NY
NPI
1568456564
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5144 Sheridan Dr
Williamsville, NY, 14221
Phone (716) 632-2311
Groups this clinician bills Medicare through
Medicare paid, 2024
$91K
1,487 services
Medicare patients, 2024
572
Average age 75
Drug cost, 2024
$86K
1,575 prescriptions
Company payments, 2025
$492
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lynn A Amarante was code 99213 (office e&m - established), 307 times for 244 patients. In total Lynn A Amarante billed 1,487 services in 44 codes, and Medicare paid $91K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 307 | 244 | $54.56 | $17K |
| 99214 Office E&M - Established | Office | 239 | 213 | $77.19 | $18K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 168 | 24 | $0.72 | $121 |
| 17110 Destruction Skin Lesion | Office | 155 | 141 | $70.18 | $11K |
| 99203 Office E&M - New | Office | 82 | 82 | $62.81 | $5,150 |
| 17111 Destruction Skin Lesion | Office | 64 | 53 | $81.82 | $5,237 |
| 11102 Skin Biopsy | Office | 64 | 61 | $64.18 | $4,108 |
| 17000 Destruction Skin Lesion | Office | 58 | 55 | $41.99 | $2,436 |
| 99204 Office E&M - New | Office | 51 | 51 | $101.56 | $5,180 |
| 17003 Destruction Skin Lesion | Office | 50 | 47 | $4.19 | $209 |
| 99212 Office E&M - Established | Office | 40 | 39 | $32.24 | $1,290 |
| 17004 Destruction Skin Lesion | Office | 28 | 28 | $106.68 | $2,987 |
| 10060 Skin | Office | 27 | 25 | $79.57 | $2,148 |
| 17282 Destruction Skin Lesion | Office | 19 | 17 | $126.10 | $2,396 |
| 17283 Destruction Skin Lesion | Office | 18 | 16 | $156.19 | $2,811 |
By year: 2022 $106K for 1,328 services; 2023 $115K for 1,494 services; 2024 $91K for 1,487 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lynn A Amarante prescribed most often to Medicare patients was Clobetasol Propionate, with 280 prescriptions and refills. In total Lynn A Amarante wrote 1,575 Medicare prescriptions that cost $86K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 280 | 326 | 169 | $13K |
| Triamcinolone Acetonide Generic | 165 | 201 | 115 | $3,279 |
| Ketoconazole Generic | 130 | 166 | 82 | $3,583 |
| Metronidazole Generic | 88 | 108 | 53 | $5,429 |
| Ciclopirox Ciclopirox Olamine | 76 | 107 | 45 | $2,031 |
| Halobetasol Propionate Generic | 63 | 72 | 42 | $4,264 |
| Doxycycline Hyclate Generic | 61 | 69 | 32 | $932 |
| Prednisone Generic | 53 | 62 | 28 | $278 |
| Betamethasone Dipropionate Generic | 45 | 51 | 31 | $4,061 |
| Mometasone Furoate Generic | 41 | 48 | 35 | $1,351 |
| Imiquimod Generic | 34 | 38 | 22 | $1,454 |
| Valacyclovir Valacyclovir Hcl | 33 | 47 | 16 | $854 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 29 | 37 | 15 | $708 |
| Ciclopirox Generic | 27 | 61 | 21 | $1,239 |
| Nystatin-Triamcinolone Nystatin/Triamcinolone Acet | 21 | 24 | Under 11 | $590 |
Brand drugs: 51 claims; generic drugs: 1,524 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lynn A Amarante $492 ($492 in general payments such as food, travel and fees) from 9 companies. The largest payer was UCB, Inc. with $126.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 5 | $126 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $114 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $63.89 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $58.58 |
| Genzyme Corporation SNY | 2 | $45.06 |
| Pfizer Inc. PFE | 1 | $26.24 |
| Abbvie Inc. ABBV | 1 | $21.75 |
| Lilly USA, LLC LLY | 1 | $19.28 |
| Galderma Laboratories, L.P. GALD.SW | 1 | $17.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.